Need help finding what you are looking for?
Contact Us
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1392054
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1392054
Pleural Diseases Market, By Disease Type, By Diagnostic Tools, By Treatment Modalities, By End User, By Geography
PUBLISHED:
PAGES: 165 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The Global Pleural Diseases Market size was valued at US$ 5.01 Bn in 2023 and is expected to reach US$ 8.13 Bn by 2030, growing at a compound annual growth rate (CAGR) of 7.2% from 2023 to 2030.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2022 | Market Size in 2023: | US$ 5.01 Bn |
| Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 - 2030 |
| Forecast Period 2023 to 2030 CAGR: | 7.20% | 2030 Value Projection: | US$ 8.13 Bn |
Figure 1. Global Pleural Diseases Market Share (%), By Region, 2023
Pleural diseases encompass a diverse group of conditions affecting the pleura, the thin membrane surrounding the lungs. These conditions can significantly impact respiratory function and overall well-being. The pleura plays a crucial role in maintaining the integrity of the lung's structure and function by providing lubrication and allowing smooth movement during breathing. Pleural diseases can arise from various causes, including infections, inflammation, tumors, and exposure to hazardous substances. Common pleural disorders include pleurisy, pleural effusion, pneumothorax and mesothelioma. Recognizing the symptoms, diagnosing accurately, and implementing appropriate treatment strategies are essential in managing and improving outcomes for individuals affected by these challenging global pleural diseases. The global global pleural diseases market has been steadily growing over the years driven by the rising prevalence of associated risk factors such as smoking, tuberculosis, and metastases. Furthermore, the market has witnessed significant technological advancements in diagnosis and treatment modalities such as imaging techniques and laser therapy, further supporting the market growth.
Market Dynamics:
The increasing adoption of inorganic strategies such as agreement is also expected to drive the growth of the market over the forecast period. For instance, in November 2020, Taiho Pharmaceutical Co., Ltd, a pharmaceutical company, and Lung Therapeutics, Inc., a clinical-stage biopharmaceutical company, announced an exclusive license agreement of LTI-01, a recombinant human single-chain urokinase plasminogen activator, currently under development by Lung Tx for loculated pleural effusions, for the territory of Japan.
However, limited awareness and delayed diagnosis, cost of diagnostic tools and treatment, limited availability of expertise and resources are expected to hamper growth of the global pleural diseases market over the forecast period.
Key features of the study:
- This report provides an in-depth analysis of the global pleural diseases market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the Global Pleural Diseases market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Bristol Myers Squibb, Merck & Co., Inc., GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Sanofi, AbbVie Inc., B. Braun SE, Becton, Dickinson and Company, Bicakcilar, Biometrix, Cook Medical, Grena, Redax, Rocket Medical, Smith Medical.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global pleural diseases market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pleural diseases market
Global Pleural Diseases Market Segmentation Detailed Segmentation:
- By Disease Types:
- Pleurisy
- Pleural Effusion
- Pneumothelioma
- Mesothelioma
- Others
- By Diagnostic Tools:
- Imaging Techniques
- Molecular Diagnostics
- Thoracoscopy and Pleuroscopy
- By Treatment Modalities:
- Medications
- Thoracentesis and Pleurodesis
- Minimally Invasive Interventions
- Surgical Interventions
- By End User:
- Hospitals and Clinics
- Diagnostic Centers
- Research and Academic Institutions
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profile:
- Bristol Myers Squibb
- Merck & Co., Inc.
- GlaxoSmithKline plc
- Boehringer Ingelheim International GmbH
- Sanofi
- AbbVie Inc.
- Braun SE
- Becton, Dickinson and Company
- Bicakcilar
- Biometrix
- Cook Medical
- Grena
- Redax
- Rocket Medical
- Smith Medical
Product Code: CMI6038
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Pleural Diseases, By Disease Type
- Market Pleural Diseases, By Diagnostic Tools
- Market Pleural Diseases, By Treatment Modalities
- Market Pleural Diseases, By End User
- Market Pleural Diseases, By Geography/Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Increasing Prevalence of Respiratory diseases
- Restraints
- Limited Availability of Expertise and Resources
- Opportunities
- Emerging Biomarkers and Precision Medicine
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Pleural Diseases Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global Pleural Diseases Market, By Disease Type, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
- Pleurisy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Pleural Effusion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Pneumothelioma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Mesothelioma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
6. Global Pleural Diseases Market, By Diagnostic Tools, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
- Imaging Techniques
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Molecular Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 20218-2030, (US$ Billion)
- Thoracoscopy and Pleuroscopy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
7. Global Pleural Diseases Market, By Treatment Modalities, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
- Medications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Thoracentesis and Pleurodesis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Minimally Invasive Interventions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Surgical Interventions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
8. Global Pleural Diseases Market, By End User, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
- Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Research and Academic Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
9. Global Pleural Diseases Market, By Region, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2019 -2030
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
10. Competitive Landscape
- Bristol Myers Squibb
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Boehringer Ingelheim International GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Braun SE
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Becton, Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bicakcilar
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Biometrix
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Cook Medical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Grena
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Redax
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Rocket Medical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Smith Medical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
11. Section
- Research Methodology
- About us
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.